It's a double edged sword of course, for investors that is. Given the history of FIRB knocking back the sale of Lynas to overseas interests and the hullabaloo of recent times Lynas is not leaving Australian control, ever.
With a smaller market for any sale of Lynas any takeover offers will have less competition.
The other aspect is that it encourages investment in non-Lynas rare earth production. Now Ausheds has reminded us continually of the greenfield issues new entrants into the RE space face, and of course he's right. But make the industry profitable enough and the market will arbitrage.
For now Lynas is in the box seat but you'd want to be watching very carefully for this not to overheat.
- Forums
- ASX - By Stock
- LYC
- Today's chart & trading
Today's chart & trading, page-1918
Featured News
Add LYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.14 |
Change
-0.200(2.72%) |
Mkt cap ! $6.673B |
Open | High | Low | Value | Volume |
$7.34 | $7.34 | $7.13 | $39.28M | 5.467M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1546 | $7.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.15 | 72361 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 25876 | 7.120 |
2 | 280 | 7.110 |
4 | 14033 | 7.100 |
2 | 77850 | 7.090 |
2 | 13233 | 7.080 |
Price($) | Vol. | No. |
---|---|---|
7.150 | 72361 | 6 |
7.160 | 1420 | 1 |
7.170 | 10329 | 1 |
7.180 | 10329 | 1 |
7.190 | 10329 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online